Efimenko 2022: Treatment with Ivermectin Is Associated with Decreased Mortality in COVID-19 Patients: Analysis of a National Federated Database

Purpose: To evaluate the difference in mortalityInternational Journal of Infectious Diseases, March 2022. 116 (Supplement), S40.  Efimenko, Nackeeran, Jabori, Gonzalez Zamora, Danker, Singh

This study followed 41,608 patients with Covid. 40,536 were treated with Remdesivir, and 1,072 were treated with Ivermectin.   Results were controlled for a number of possible confounds such as diabetes, 

Ivermectin had a 70% decreased mortality, with  p<0.0001  (which means there is only a 1 in 10,000 chance this could have been a coincidence or accident.)

CONCLUSION:  “Ivermectin use was associated with decreased mortality in patients with COVID-19 compared to remdesivir.”

The same video discusses a second study about prevention of Covid via Ivermectin.  See Kerr et al (2022).

I am grateful this video has not been removed (yet) from Youtube.  Watch it while you can. 

EDITED 3/19/2022:  Unfortunately, the “fact checkers” decided that they don’t like this video, and they have removed it altogether.  So instead of Dr. Campbell leading you through the study, spend a few minutes reading it yourself before it, too, is removed.  Such is the state of science today.

MedLine || Full Text

This entry was posted in 2021-2025, COVID-19, Ivermectin. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *